Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
Special Offer: Just $199
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.07 (+0.71%)
TSLA   183.03 (+0.09%)
NVDA   158.20 (-2.77%)
NIO   10.13 (-0.39%)
BABA   75.90 (+0.53%)
AMD   73.17 (-2.62%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.07 (+0.71%)
TSLA   183.03 (+0.09%)
NVDA   158.20 (-2.77%)
NIO   10.13 (-0.39%)
BABA   75.90 (+0.53%)
AMD   73.17 (-2.62%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.07 (+0.71%)
TSLA   183.03 (+0.09%)
NVDA   158.20 (-2.77%)
NIO   10.13 (-0.39%)
BABA   75.90 (+0.53%)
AMD   73.17 (-2.62%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
S&P 500   3,963.94 (-1.54%)
DOW   33,849.46 (-1.45%)
QQQ   282.88 (-1.41%)
AAPL   144.49 (-2.44%)
MSFT   241.12 (-2.57%)
META   108.74 (-2.40%)
GOOGL   96.05 (-1.45%)
AMZN   94.07 (+0.71%)
TSLA   183.03 (+0.09%)
NVDA   158.20 (-2.77%)
NIO   10.13 (-0.39%)
BABA   75.90 (+0.53%)
AMD   73.17 (-2.62%)
T   18.79 (-1.73%)
MU   55.74 (-4.57%)
CGC   3.41 (-6.83%)
F   13.73 (-2.49%)
GE   85.49 (-3.01%)
DIS   95.70 (-3.21%)
AMC   7.36 (-2.00%)
PYPL   79.88 (-0.25%)
PFE   49.58 (+0.75%)
NFLX   281.33 (-1.47%)
NASDAQ:MLAB

Mesa Laboratories - MLAB Stock Forecast, Price & News

$169.71
-6.62 (-3.75%)
(As of 11/28/2022 03:59 PM ET)
Add
Compare
Today's Range
$169.71
▼
$175.77
50-Day Range
$118.55
▼
$188.84
52-Week Range
$114.21
▼
$333.42
Volume
3,223 shs
Average Volume
43,004 shs
Market Capitalization
$905.74 million
P/E Ratio
N/A
Dividend Yield
0.36%
Price Target
$166.00

Mesa Laboratories MarketRank™ Forecast

Analyst Rating
N/A
0.00 Rating Score
Upside/​Downside
2.2% Downside
$166.00 Price Target
Short Interest
Bearish
7.30% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.40mentions of Mesa Laboratories in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$438,625 Sold Last Quarter
Proj. Earnings Growth
1.99%
From $6.52 to $6.65 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.89 out of 5 stars

Medical Sector

1037th out of 1,040 stocks

Process Control Instruments Industry

11th out of 11 stocks

See Top Rated MarketRank™ Stocks Here
MLAB stock logo

About Mesa Laboratories (NASDAQ:MLAB) Stock

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Stock News Headlines

November 28, 2022 | americanbankingnews.com
Mesa Laboratories, Inc. (NASDAQ:MLAB) Plans Quarterly Dividend of $0.16
November 24, 2022 | americanbankingnews.com
John Bradley Schmieder Sells 2,500 Shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) Stock
November 24, 2022 | americanbankingnews.com
Mesa Laboratories (NASDAQ:MLAB) Stock Price Down 7.8% on Insider Selling
November 23, 2022 | msn.com
Mesa Laboratories's Return On Capital Employed Insights
November 23, 2022 | finance.yahoo.com
Earnings Estimates Moving Higher for Mesa Labs (MLAB): Time to Buy?
November 22, 2022 | markets.businessinsider.com
Why Mesa Laboratories (MLAB) Stock Is Getting Hammered Today
November 18, 2022 | nasdaq.com
Conestoga Capital Ups Stake in Mesa Laboratories (MLAB)
November 17, 2022 | finance.yahoo.com
Mesa Labs Acquires Belyntic’s Peptide Purification Business
November 8, 2022 | finance.yahoo.com
Mesa Laboratories Second Quarter 2023 Earnings: Beats Expectations
November 4, 2022 | finance.yahoo.com
Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director
November 3, 2022 | finance.yahoo.com
Mesa Labs (MLAB) Q2 Earnings and Revenues Top Estimates
October 25, 2022 | finance.yahoo.com
Further weakness as Mesa Laboratories (NASDAQ:MLAB) drops 7.8% this week, taking one-year losses to 60%
October 15, 2022 | seekingalpha.com
MLAB Mesa Laboratories, Inc.
September 11, 2022 | finance.yahoo.com
Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares Could Be 39% Below Their Intrinsic Value Estimate
September 9, 2022 | seekingalpha.com
Mesa Laboratories: Softening Bottom Line Fundamentals, Fairly Priced
August 6, 2022 | seekingalpha.com
Mesa Laboratories, Inc. 2023 Q1 - Results - Earnings Call Presentation
August 4, 2022 | finance.yahoo.com
Mesa Labs (MLAB) Q1 Earnings and Revenues Miss Estimates
July 28, 2022 | finance.yahoo.com
Mesa Labs (MLAB) to Report Q1 Results: Wall Street Expects Earnings Growth
July 7, 2022 | marketwatch.com
Mesa Laboratories stock price target cut to $240 from $295 at J.P. Morgan
June 27, 2022 | finance.yahoo.com
Mesa Laboratories Appoints Tony Tripeny to its Board of Directors
May 31, 2022 | nasdaq.com
Mesa Labs (MLAB) Surpasses Q4 Earnings and Revenue Estimates
May 26, 2022 | seekingalpha.com
Mesa Laboratories goes ex-dividend tomorrow
May 13, 2022 | finance.yahoo.com
The five-year decline in earnings for Mesa Laboratories NASDAQ:MLAB) isn't encouraging, but shareholders are still up 55% over that period
April 26, 2022 | nasdaq.com
Mesa Laboratories is Now Oversold (MLAB)
April 12, 2022 | finance.yahoo.com
News Flash: Analysts Just Made A Captivating Upgrade To Their Mesa Laboratories, Inc. (NASDAQ:MLAB) Forecasts
See More Headlines
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Company Calendar

Last Earnings
5/31/2021
Ex-Dividend for 9/15 Dividend
8/30/2022
Dividend Payable
9/15/2022
Today
11/28/2022
Ex-Dividend for 12/15 Dividend
11/29/2022
Dividend Payable
12/15/2022
Next Earnings (Estimated)
2/02/2023
Fiscal Year End
3/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Process control instruments
Sub-Industry
Electronic Equipment & Instruments
Sector
Medical
Current Symbol
NASDAQ:MLAB
CUSIP
59064R10
CIK
724004
Web
www.mesalabs.com
Phone
(303) 987-8000
Fax
303-987-8989
Employees
506
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$166.00
High Stock Price Forecast
$166.00
Low Stock Price Forecast
$166.00
Forecasted Upside/Downside
-2.2%
Consensus Rating
N/A
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

EPS (Most Recent Fiscal Year)
($0.76)
Trailing P/E Ratio
N/A
Forward P/E Ratio
26.03
P/E Growth
N/A
Net Income
$1.87 million
Net Margins
-1.78%
Pretax Margin
-1.98%
Return on Equity
6.71%
Return on Assets
3.74%

Debt

Debt-to-Equity Ratio
0.53
Current Ratio
2.80
Quick Ratio
2.13

Sales & Book Value

Annual Sales
$184.34 million
Price / Sales
4.91
Cash Flow
$10.83 per share
Price / Cash Flow
15.67
Book Value
$75.07 per share
Price / Book
2.26

Miscellaneous

Outstanding Shares
5,337,000
Free Float
5,043,000
Market Cap
$905.74 million
Optionable
Not Optionable
Beta
0.60

Key Executives

  • Mr. Gary M. OwensMr. Gary M. Owens (Age 54)
    CEO, Pres & Director
    Comp: $1.66M
  • Mr. John V. SakysMr. John V. Sakys (Age 53)
    VP, CFO & Chief Accounting Officer
    Comp: $759.57k
  • Mr. Brian David ArchboldMr. Brian David Archbold (Age 46)
    Sr. VP of Continuous Improvement
    Comp: $509.89k
  • Ms. Gina Hinman Trulli
    VP of HR
  • Mr. Bryan T. Leo
    Sr. VP of Operations
  • Mr. Garrett Krushefski
    Sr. VP of Operations
  • Mr. Peter M. Dansky (Age 61)
    Pres of Clinical Genomics

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













MLAB Stock - Frequently Asked Questions

What is Mesa Laboratories' stock price forecast for 2023?

0 equities research analysts have issued 12-month price targets for Mesa Laboratories' stock. Their MLAB share price forecasts range from $166.00 to $166.00. On average, they expect the company's stock price to reach $166.00 in the next year. This suggests that the stock has a possible downside of 3.7%.
View analysts price targets for MLAB or view top-rated stocks among Wall Street analysts.

How have MLAB shares performed in 2022?

Mesa Laboratories' stock was trading at $328.09 on January 1st, 2022. Since then, MLAB shares have decreased by 47.4% and is now trading at $172.46.
View the best growth stocks for 2022 here.

Are investors shorting Mesa Laboratories?

Mesa Laboratories saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 373,900 shares, an increase of 17.5% from the October 31st total of 318,300 shares. Based on an average trading volume of 69,500 shares, the short-interest ratio is presently 5.4 days. Currently, 7.3% of the company's shares are short sold.
View Mesa Laboratories' Short Interest.

When is Mesa Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 2nd 2023.
View our MLAB earnings forecast.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) released its quarterly earnings results on Monday, May, 31st. The medical instruments supplier reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.91 by $0.17. The medical instruments supplier earned $37.96 million during the quarter, compared to the consensus estimate of $34.92 million. Mesa Laboratories had a positive trailing twelve-month return on equity of 6.71% and a negative net margin of 1.78%.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories announced a quarterly dividend on Monday, October 3rd. Investors of record on Wednesday, November 30th will be given a dividend of $0.16 per share on Thursday, December 15th. This represents a $0.64 annualized dividend and a yield of 0.37%. The ex-dividend date is Tuesday, November 29th.
Read our dividend analysis for MLAB.

Is Mesa Laboratories a good dividend stock?

Mesa Laboratories (NASDAQ:MLAB) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.36%.
Read our dividend analysis for MLAB.

What is Gary Owens' approval rating as Mesa Laboratories' CEO?

5 employees have rated Mesa Laboratories Chief Executive Officer Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among the company's employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and (BDX).

What is Mesa Laboratories' stock symbol?

Mesa Laboratories trades on the NASDAQ under the ticker symbol "MLAB."

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (16.16%), Conestoga Capital Advisors LLC (9.18%), Vanguard Group Inc. (6.54%), Royce & Associates LP (4.72%), State Street Corp (3.92%) and Kayne Anderson Rudnick Investment Management LLC (2.72%). Insiders that own company stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys and Robert V Dwyer.
View institutional ownership trends.

How do I buy shares of Mesa Laboratories?

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Mesa Laboratories' stock price today?

One share of MLAB stock can currently be purchased for approximately $172.46.

How much money does Mesa Laboratories make?

Mesa Laboratories (NASDAQ:MLAB) has a market capitalization of $920.42 million and generates $184.34 million in revenue each year. The medical instruments supplier earns $1.87 million in net income (profit) each year or ($0.76) on an earnings per share basis.

How many employees does Mesa Laboratories have?

The company employs 506 workers across the globe.

How can I contact Mesa Laboratories?

Mesa Laboratories' mailing address is 12100 W 6TH AVE, LAKEWOOD CO, 80228. The official website for the company is www.mesalabs.com. The medical instruments supplier can be reached via phone at (303) 987-8000, via email at investorrelations@mesalabs.com, or via fax at 303-987-8989.

This page (NASDAQ:MLAB) was last updated on 11/28/2022 by MarketBeat.com Staff